Sun Pharmaceutical Industries Analyzed: A Quick Look
Sun Pharmaceutical Industries’ stock price was trading at Rs 1761 today, showing a slight increase of 0.05%. However, looking back over the past year, the stock has actually lost 4.18% of its value, while the broader NIFTY index has grown by 10.11% and the Nifty Pharma index by 0.66%. This indicates that Sun Pharma hasn’t kept pace with the overall market and its sector.
Key Points
- Sun Pharma stock rose today but lagged behind market growth.
- Year-to-date, Sun Pharma underperformed both NIFTY and Nifty Pharma.
- NIFTY and Sensex down today; Pharma Index saw slight increase.
- Stock volume was slightly lower than the recent monthly average.
- Sun Pharma’s PE ratio is currently high at 90.36.
- January futures contract shows a small price increase today.
Recent Performance
In the last month, Sun Pharma’s stock has dropped by approximately 1.96%. At the same time, the Nifty Pharma index, which includes Sun Pharma, has fallen by about 2.31%. This suggests a potential weakness within the pharmaceutical sector itself. The trading volume today was 17.39 million shares, which is a little lower than the average of 18.59 million shares seen over the last month.
Future Contract Details
The contract for January of Sun Pharma’s stock was trading at Rs 1769.3, indicating a small increase of 0.23% for the day. This future contract reflects investor expectations for the stock’s potential movement in the coming month. The stock’s PE ratio, calculated using the most recent earnings data, is currently 90.36, a figure that’s worth considering when evaluating the stock’s value.
The benchmark NIFTY is down around 0.36% today, and the Sensex is also down 0.36%. This overall market decline is impacting several stocks, including Sun Pharma.
Ultimately, Sun Pharmaceutical needs to demonstrate stronger growth to regain investor confidence and compete effectively.
